Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Approves Another Assay for NT-proBNP
Link ID 4158
Title FDA Approves Another Assay for NT-proBNP
Url http://www.medscape.com/viewarticle/571777?src=rss
Description The FDA has granted market clearance to the automated VIDAS NT-proBNP assay. Heartwire
Category Articles > Business of Medicine
Keywords
Date Mar 21, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Malaria Campaigners Hopeful on Drugs Pricing Deal
  Anti-malaria campaigners are confident that a deal can be reached with pharmaceuticals groups to cut the cost of new drugs needed to fight a disease estimated to kill more than 1 million people a year. Reuters Health Information
Category:   Articles > Business of Medicine


2. Fentanyl Pain Patch Recalled
  Voluntary recall of duragesic and generic fentanyl patch was due to overdose risk. WebMD Health News
Category:   Articles > Business of Medicine


3. Fluoroquinolone Restriction Policy Reduces Use in Elderly Population
  Formulary restrictions to fluoroquinolones can reduce their use without causing an increase in hospital admission rates among the elderly, according to a report in the October issue of The American Journal of Medicine. Reuters Health Information
Category:   Articles > Business of Medicine


4. Patients, Caregivers, and the Danger of Imaging Studies: The Four Horsemen of the Radiology Apocalyp
  The subject of radiation-induced cancer from CT is controversial, and is disputed, primarily by radiologists, citing lack of scientific evidence.
Medscape Radiology
Category:   Articles > Business of Medicine


5. Aetna Profit Down on Investments, but Meets Views
  Aetna Inc posted a 44 percent drop in third-quarter profit on Wednesday, hurt by investment losses stemming from the credit crisis, and the No. 3 U.S. health insurer lowered its full-year forecast slightly. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS